Century Therapeutics (IPSC): Officer filed to sell ~$404
Carr Douglas, Officer at Century Therapeutics, filed to sell ~$404 of Century Therapeutics shares.
- ~$404
- planned to sell · 266 shares, around Nov 3, 2026
- Planned for
- Nov 3, 2026
- Notice filed
- Nov 3, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 8, 2026Insider · 2 peopleInsiders: 2 sales (~$2K)
- Sep 9, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 9, 2026, the Board of Directors (the “Board”) of Century Therapeutics, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased its size from six to seven directors and appointed Mr. Joseph Truitt as a member of the Board, effective as of September 9, 2026 (the “Effective Date”).”
- Sep 14, 2026Insider · 2 peopleInsiders: 2 sales (~$8K)
- Nov 3, 2026InsiderOfficer sold ~$404 of IPSC shares in the open market
What came next
How to read SEC Form 144
Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.
Full guide: What is an SEC Form 144?
What else is on file for Century Therapeutics
For Century Therapeutics, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IPSC page.
How this filing works
Explore the data
Other disclosures at Century Therapeutics
- SEC Form 4Nov 5, 2026
- SEC Form 4Sep 15, 2026
- SEC Form 4Sep 15, 2026
- SEC Form 4Sep 9, 2026
- SEC Form 4Sep 9, 2026
- SEC Form 4Aug 5, 2026
Everything OQRO holds on this company is on its IPSC page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
